Speaking about this breakthrough release, incoming Fender CEO and current President of Fender APAC, Edward ‘Bud’ Cole, says, ...
Evidence from multiple model systems supports a shift away from heme transport and toward metabolic dysfunction and oxidative stress as key drivers of TANGO2 deficiency.